Sangamo Licenses Capsid Tech to Lilly for CNS Genomic Medicines Sangamo Therapeutics, Inc., a leader in genomic medicine, has entered into a new licensing agreement with Eli Lilly and Company (“Lilly”), a global pharmaceutical powerhouse, to advance treatments for neurological…
J&J Finalizes Intra-Cellular Therapies Acquisition, Strengthens Neuroscience Leadership Johnson & Johnson (NYSE: JNJ) has officially completed its acquisition of Intra-Cellular Therapies, Inc., marking a significant expansion of its neuroscience portfolio. Intra-Cellular Therapies will now operate as a business unit within…
Columbus Unites to Support Life-Saving Research and Patient Care at the 2025 Susan G. Komen Race for the Cure Susan G. Komen®, the world’s leading breast cancer organization, has announced the return of its signature Race for the Cure event…
Amneal Launches BORUZU, Ready-to-Use Bortezomib Injection Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”), a global biopharmaceutical company, and Shilpa Medicare Limited (“Shilpa”) have officially announced the U.S. launch of BORUZU™, a new ready-to-use formulation of bortezomib designed for subcutaneous and…
Gameday Men’s Health Appoints Dr. Haleem Mohammed as CMO to Lead National Expansion Gameday Men’s Health, a leading men’s health clinic dedicated to redefining wellness through cutting-edge treatments and personalized concierge-level care, has announced the appointment of Dr. Haleem Mohammed,…
Mirion Enhances Radiopharmaceutical Production with Cutting-Edge Apex-Guard Software Mirion Technologies (NYSE: MIR), a global leader in radiation safety solutions, has announced the latest release of its Apex-Guard gamma spectroscopy software. Designed to meet the rigorous regulatory standards for commercial radioisotope…
Maternal sepsis is a life-threatening condition that arises from an infection during pregnancy, childbirth, post-abortion, or the postpartum period. It is a significant public health challenge and ranks as the third leading cause of maternal mortality worldwide. In addition to…
WHO Experts Plan Bold Steps to Strengthen Global Immunization The World Health Organization’s Strategic Advisory Group of Experts on Immunization (SAGE) has raised significant concerns about mounting pressures that threaten global vaccination efforts. During its latest meeting from March 10…
Altasciences Wins 2025 CDMO Leadership Award for Small Molecule Dosage Altasciences, a prominent contract development and manufacturing organization (CDMO), has once again been recognized for its excellence in the pharmaceutical industry. The company, which has previously won the CRO Leadership…
Global Cancer Antibody Drug Conjugates Market Report 2024: Industry Growth, Drug Approvals, and Market Expansion The latest report, “Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030,” has been added to ResearchAndMarkets.com’s portfolio.…
Pharma 4.0 Market Report 2025: Projected Growth and Technological Advancements The “Pharma 4.0 – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering, providing an extensive analysis of the evolving Pharma 4.0 market. The global market, valued at $13.7…
Merck’s SC Pembrolizumab Shows Noninferior PK to IV KEYTRUDA in Trial Merck, known as MSD outside of the United States and Canada, has presented the first data from the pivotal 3475A-D77 Phase 3 trial evaluating subcutaneous pembrolizumab in combination with…